Re: Placebo or Standard of Care
|
|
Resverlogix Corp.
|
Nov 02, 2019 06:03PM
|
Re: Placebo or Standard of Care
|
1
|
Resverlogix Corp.
|
Nov 02, 2019 05:47PM
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
5
|
Zenith Epigenetics
|
Nov 02, 2019 03:00PM
|
Re: Transcript RVX_191031_AGM
|
3
|
Resverlogix Corp.
|
Nov 02, 2019 04:09AM
|
Re: Webcast is up
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 08:10PM
|
Re: Wow talk about saying....
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 08:05PM
|
Re: Just back from IR,...
|
2
|
Resverlogix Corp.
|
Oct 31, 2019 03:07PM
|
Re: Just back from IR,...
|
3
|
Resverlogix Corp.
|
Oct 29, 2019 07:29PM
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 29, 2019 02:49PM
|
Re: I just can’t see the management going
|
3
|
Resverlogix Corp.
|
Oct 29, 2019 02:22PM
|
Re: Just back from IR,...
|
2
|
Resverlogix Corp.
|
Oct 27, 2019 11:15AM
|
Re: Just back from IR,...
|
3
|
Resverlogix Corp.
|
Oct 27, 2019 11:14AM
|
Re: Just back from IR,...
|
6
|
Resverlogix Corp.
|
Oct 26, 2019 11:07AM
|
Re: Over 700K traded in Canada today....
|
3
|
Resverlogix Corp.
|
Oct 25, 2019 05:35PM
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
7
|
Zenith Epigenetics
|
Oct 25, 2019 11:07AM
|
Re: BIO Investor Forum, Oct 22-23
|
2
|
Zenith Epigenetics
|
Oct 24, 2019 07:51PM
|
Re: BIO Investor Forum, Oct 22-23
|
1
|
Zenith Epigenetics
|
Oct 24, 2019 04:42PM
|
Re: BIO Investor Forum, Oct 22-23
|
2
|
Zenith Epigenetics
|
Oct 24, 2019 04:18PM
|
Re: Breaking down the Webcast
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 01:36PM
|
Re: Options
|
1
|
Resverlogix Corp.
|
Oct 23, 2019 12:41PM
|